Grant received in 2022
DCCC has funded 125.000 DKK to the project.
In 2020 and 2021, ObeCaRe received support from DCCC in the categories "Preparatory meetings/networks with a view to "center formations" of an interdisciplinary and national nature" and "Establishment of new national, interdisciplinary networks DCCC supports the establishment of national, interdisciplinary networks", respectively .
This funding led to the establishment of the ObeCaRe network and several interdisciplinary projects focusing on obesity and cancer. This has successfully led to the holding of two productive national 2-day symposia for 40+ participants in Nyborg, June 2021 and 2022.
There is still a need to spread the knowledge already achieved, future ambitions and ongoing ambitions in the area with which this project can contribute. This project will therefore support targeted dissemination of the obesity-cancer connection through increased communication at a 3rd national symposium in 2023.
The long-term aim is, via the understanding of the underlying molecular mechanisms of the obesity-cancer connection, to improve survival among cancer patients with simultaneous overweight and obesity.
Multidisciplinary organisation
The application is anchored in the DCCC-supported national network ObeCaRe
Project stakeholders
The five ObeCaRe work packages are headed and coordinated by:
- DEIRDRE CRONIN FENTON, AU, Clinical Epidemiology; cancer epidemiology
- SIGNE BORGQUIST, AUH, Oncology; clinical/translational oncology
- RIKKE HJORTEBJERG, SDU, Experimental Endocrinology; translational obesity
- ROBERT ZACHARIAE, AUH, Psycho-Oncology and Health Psychology; biopsychosocial cancer research, DCCL board
- JENS MELDGAARD BRUUN, AUH, National Center of Obesity, Endocrinology; clini-cal/experimental obesity
The ObeCaRe faculty members are distributed across disciplines on a national level with support from international experts in the field:
CAPITAL REGION OF DENMARK
- CAMILLA SCHEELE, KU, NNF Center for Basic Metabolic Research; adipocyte biology
- SØREN NIELSEN, RH, Centre for Physical Activity Research; life style intervention
- CLAUS HØGDALL, RH, Gynecology; translational gynecology, chair DCGG
- CHRISTOFFER JOHANSEN, RH, Oncology; psychological oncology
- ANNE TJØNNELAND, Danish Cancer Society; cancer epidemiology
- PETER BUSCH ØSTERGREN, RH, Urology, prostate cancer
- GITTE LAUB HANSEN, Danish Cancer Society; cancer communication
REGION ZEALAND
- SUSANNE DALTON, Danish Cancer Society and National Research Center for Equality in Cancer, cancer epidemiology
CENTRAL DENMARK REGION
- NIELS JESSEN, AU, STENO Diabetes; clinical/translational endocrinology
- TINNE LAURBERG, AUH, Pathology; translational pathology
- ANNELLI SANDBÆK, AUH, Public Health; general medicine, communication
- HENRIK TOFT SØRENSEN, AU, Clinical Epidemiology; cancer trials and epidemiology
- PETER CHRISTENSEN, AUH, Surgery, pelvic cancer surgery
- LENE HJERRILD IVERSEN, AUH, Surgery; colorectal cancer, surgery
- MICHAEL BORRE, AUH, Urology; prostate cancer, chair DMCG
REGION OF NORTH DENMARK
- CHARLOTTE BIRKMOSE ROTBØLL, AAUH, Oncology; oncology
RANDI TOBBERUP, AAUH, Oncology; dietician
- REGION OF SOUTHERN DENMARK
- JAN FRYSTYK, OUH, SDU; Endocrinology, chair; translational endocrinology/obesity
- RIKKE HJORTEBJERG, OUH, SDU; translational onco-endocrinology
- MARIANNE EWERTZ, SDU, Oncology; clinical breast oncology
- PER PFEIFFER, OUH, Oncology; clinical GI-oncology
INTERNATIONAL ADVISORY BOARD
- ANDREW RENEHAN, University of Manchester, MANCHESTER CANCER RESEARCH CENTRE
- ANN ROSENDAHL, Lund University, Oncology
- CHRISTIAN RASK MADSEN, Harvard Medical School, Joslin Diabetes Center